Fabrizia Gelardi

CV
h-index11
4papers
8citations
Novelty39%
AI Score43

4 Papers

CVOct 31, 2025Code
Context-Gated Cross-Modal Perception with Visual Mamba for PET-CT Lung Tumor Segmentation

Elena Mulero Ayllón, Linlin Shen, Pierangelo Veltri et al.

Accurate lung tumor segmentation is vital for improving diagnosis and treatment planning, and effectively combining anatomical and functional information from PET and CT remains a major challenge. In this study, we propose vMambaX, a lightweight multimodal framework integrating PET and CT scan images through a Context-Gated Cross-Modal Perception Module (CGM). Built on the Visual Mamba architecture, vMambaX adaptively enhances inter-modality feature interaction, emphasizing informative regions while suppressing noise. Evaluated on the PCLT20K dataset, the model outperforms baseline models while maintaining lower computational complexity. These results highlight the effectiveness of adaptive cross-modal gating for multimodal tumor segmentation and demonstrate the potential of vMambaX as an efficient and scalable framework for advanced lung cancer analysis. The code is available at https://github.com/arco-group/vMambaX.

CVMay 13
Cross Modality Image Translation In Medical Imaging Using Generative Frameworks

Giulia Romoli, Alessia Capoccia, Filippo Ruffini et al.

Medical image-to-image (I2I) translation enables virtual scanning, i.e. the synthesis of a target imaging modality from a source one without additional acquisitions. Despite growing interest, most proposed methods operate on 2D slices, are evaluated on isolated tasks with different experimental set-ups and lack clinical validation. The primary contribution of this work is a reproducible, standardized comparative evaluation of 3D I2I translation methods in oncological imaging, designed to standardize preprocessing, splitting, inference, and multi-level evaluation across heterogeneous clinical tasks. Within this framework, we compare seven generative models, three Generative Adversarial Networks (GANs: Pix2Pix, CycleGAN, SRGAN) and four latent generative models (Latent Diffusion Model, Latent Diffusion Model+ControlNet, Brownian Bridge, Flow Matching), across eleven datasets spanning three anatomical regions (head/neck, lung, pelvis) and four translation directions (cone-beam CT to CT, MRI to CT, CT to PET, MRI T2-weighted to T2-FLAIR), for a total of 77 experiments under uniform training, inference, and evaluation conditions. The results show that GANs outperform latent generative models across all tasks, with SRGAN achieving statistically significant superiority. Our lesion-level analysis reveals that all models struggle with small lesions and that, in CT to PET synthesis, models reproduce lesion shape more reliably than absolute uptake-related intensity. We also performed a Visual Turing test administered to 17 physicians, including 15 radiologists, which shows near-chance classification accuracy (56.7%), confirming that synthetic volumes are largely indistinguishable from real acquisitions, while exposing a dissociation between quantitative metrics and clinical preference.

CVMay 4
Virtual Scanning for NSCLC Histology: Investigating the Discriminatory Power of Synthetic PET

Fatih Aksu, Laura Ciuffetti, Francesco Di Feola et al.

Accurate histological differentiation between adenocarcinoma (ADC) and squamous cell carcinoma (SCC) is critical for personalized treatment in non-small cell lung cancer (NSCLC). While [$^{18}$F]FDG PET/CT is a standard tool for the clinical evaluation of lung cancer, its utility is often limited by high costs and radiation exposure. In this paper, we investigate the feasibility of "virtual scanning" as a feature-enhancement strategy by evaluating whether synthetic PET data can provide complementary feature representations to supplement anatomical CT scans in histological subtype classification. We propose a framework that leverages a 3D Pix2Pix Generative Adversarial Network (GAN), pretrained on the FDG-PET/CT Lesions dataset, to synthesize pseudo-PET volumes from anatomical CT scans. These synthetic volumes are integrated with structural CT data within the MINT framework, a multi-stage intermediate fusion architecture. Our experiments, conducted on a multi-center dataset of 714 subjects, demonstrate that the inclusion of synthetic metabolic features significantly improves classification performance over a CT-only baseline. The multimodal approach achieved a statistically significant increase in the Area Under the Curve (AUC) from 0.489 to 0.591 and improved the Geometric Mean (GMean) from 0.305 to 0.524. These results suggest that synthetic PET scans provide discriminatory metabolic cues that enable deep learning models to exploit complementary cross-modal information, offering a potential feature-enhancement strategy for clinical scenarios where physical PET scans are unavailable.

IVJan 21, 2025
Multi-stage intermediate fusion for multimodal learning to classify non-small cell lung cancer subtypes from CT and PET

Fatih Aksu, Fabrizia Gelardi, Arturo Chiti et al.

Accurate classification of histological subtypes of non-small cell lung cancer (NSCLC) is essential in the era of precision medicine, yet current invasive techniques are not always feasible and may lead to clinical complications. This study presents a multi-stage intermediate fusion approach to classify NSCLC subtypes from CT and PET images. Our method integrates the two modalities at different stages of feature extraction, using voxel-wise fusion to exploit complementary information across varying abstraction levels while preserving spatial correlations. We compare our method against unimodal approaches using only CT or PET images to demonstrate the benefits of modality fusion, and further benchmark it against early and late fusion techniques to highlight the advantages of intermediate fusion during feature extraction. Additionally, we compare our model with the only existing intermediate fusion method for histological subtype classification using PET/CT images. Our results demonstrate that the proposed method outperforms all alternatives across key metrics, with an accuracy and AUC equal to 0.724 and 0.681, respectively. This non-invasive approach has the potential to significantly improve diagnostic accuracy, facilitate more informed treatment decisions, and advance personalized care in lung cancer management.